Stephen A. Berenson

Age : 61

Patrimoine public : 3 756 374 USD

Principales sociétés :

Moderna, Inc. -

Seres Therapeutics, Inc.

Synthèse

Presently, Stephen A. Berenson occupies the position of Chairman at Seres Therapeutics, Inc., Chairman of Cellarity Inc. and Managing Partner at Flagship Pioneering. Mr. Berenson is also on the board of CiBO Technologies, Inc., Moderna, Inc., The Mahaiwe Performing Arts Center and Repertoire Immune Medicines, Inc.

He received an undergraduate degree from Massachusetts Institute of Technology.

Postes et responsabilités de Stephen A. Berenson

Nom	Titre	Depuis
Moderna, Inc. (Recherche biotechnologique et médicale)	Independent Non-Executive Director	2017
Seres Therapeutics, Inc. (Recherche biotechnologique et médicale)	Chairman	2019
Cellarity Inc.	Chairman	-
CiBO Technologies, Inc.	Director	-
The Mahaiwe Performing Arts Center	Trustee	-
Repertoire Immune Medicines, Inc.	Director	-
Flagship Pioneering	Managing Partner	-

Participations de Stephen A. Berenson

Nom	Actions	%	Valorisation
Moderna, Inc. (MRNA) (Recherche biotechnologique et médicale)	20 801	0,0054%	3 736 276 USD
Seres Therapeutics, Inc. (MCRB) (Recherche biotechnologique et médicale)	3 589	0,0029%	20 098 USD

Stephen A. Berenson: Réseau personnel

Nom	Sociétés liées
Noubar Afeyan	Moderna, Inc. Seres Therapeutics, Inc. Repertoire Immune Medicines, Inc. Cellarity Inc. Flagship Pioneering CiBO Technologies, Inc.
David A. Berry	Seres Therapeutics, Inc. Flagship Pioneering
Sandra J. Horning	Moderna, Inc. Cellarity Inc.
Stéphane Bancel	Moderna, Inc. Flagship Pioneering
Marcello Damiani	Moderna, Inc. Cellarity Inc.
Grégory Behar	Seres Therapeutics, Inc.
Jeff York	Seres Therapeutics, Inc.
Lisa von Moltke	Seres Therapeutics, Inc.
Marcus Chapman	Seres Therapeutics, Inc.
Eric D. Shaff	Seres Therapeutics, Inc.